# Catalent Belgium SA - Inspection Records Source: https://www.globalkeysolutions.net/companies/catalent-belgium-sa/f48653bf-84a2-4aeb-bdc3-ca2d0cc4fdf2 > Inspection records and compliance data for Catalent Belgium SA in Brussels-Capital Region, None. Access full analysis and detailed observations. --- ## Details - Name: Catalent Belgium SA - FEI Number: 3007647000 - City: Brussels-Capital Region - State: None - Country Name: Belgium - Address Line 1: Font Saint-Landry 10 - Address Line 2: Brussels - Zip Code: None - Facility Type: Finished drug product manufacturer - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [483 - Catalent Belgium SA - Unknown Date](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/8c3c7fa7-4d02-435e-bfa7-eca8c01018fd) — source: FDA, date: Invalid Date - [483 - Catalent Belgium SA - 2026-02-07](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/fa83cb21-e34f-4eac-9039-a029ee5ef976) — source: FDA, date: February 7, 2026 - [483 - Catalent Belgium SA - 2024-07-12](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/95dfaf1f-b957-49b3-84a4-d94cf642abc4) — source: FDA, date: July 12, 2024 - [FDA Inspection 1246550 - Catalent Belgium SA - 2023-04-07](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/2a839d52-c7a1-4ba3-9abd-72da042e0df1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 7, 2023 - [483 - Catalent Belgium SA - 2022-08-19](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/39127879-6006-4bf9-9097-c58baca0283e) — source: FDA, date: August 19, 2022 - [EIR - Catalent Belgium SA - 2022-08-19](https://www.globalkeysolutions.net/records/eir/catalent-belgium-sa/885f1132-6075-4922-909a-a5d88ab0e69d) — source: FDA, date: August 19, 2022 - [483 - Catalent Belgium SA - 2022-08-19](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/a5641d00-652f-47a6-a7f2-a1b291a6e2c8) — source: FDA, date: August 19, 2022 - [FDA Inspection 1177876 - Catalent Belgium SA - 2022-08-19](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/cda7d2d2-9318-4cf2-9c5a-332cc4e11987) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2022 - [483 - Catalent Belgium SA - 2021-10-26](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/5f428877-75e7-4d0c-a321-d784b42dae0b) — source: FDA, date: October 26, 2021 - [483 - Catalent Belgium SA - 2021-10-26](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/93f734e2-857b-42f7-a28d-23a89c5695ba) — source: FDA, date: October 26, 2021 - [FDA Inspection 1136201 - Catalent Belgium SA - 2020-01-22](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/718d5f13-8833-4845-b87e-2fd3dce9c475) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 22, 2020 - [483 - Catalent Belgium SA - 2019-06-19](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/0bdc03da-0772-4c63-92a1-bf5a5e92ae50) — source: FDA, date: June 19, 2019 - [FDA Inspection 1093395 - Catalent Belgium SA - 2019-06-19](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/8808ef61-857f-4e6e-ad95-cd1aacefd7ff) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2019 - [FDA Inspection 1061068 - Catalent Belgium SA - 2018-07-31](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/7d7ec872-9d8f-4a15-82c9-a72e04b548cf) — classification: No Action Indicated (NAI), source: FDA, date: July 31, 2018 - [483 - Catalent Belgium SA - 2017-07-07](https://www.globalkeysolutions.net/records/483/catalent-belgium-sa/53e42813-d6b8-477e-883e-6b1c94f2e69f) — source: FDA, date: July 7, 2017 - [FDA Inspection 1019956 - Catalent Belgium SA - 2017-07-07](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/05c3d94e-0d81-4422-ba2b-2c72ec462b3b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 7, 2017 - [FDA Inspection 996402 - Catalent Belgium SA - 2016-11-25](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/e68d342f-28b8-48c3-81ff-9c0e1951ee63) — classification: No Action Indicated (NAI), source: FDA, date: November 25, 2016 - [FDA Inspection 996402 - Catalent Belgium SA - 2016-11-25](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/3d6c9207-9922-433e-a17d-c31880f970e1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 25, 2016 - [FDA Inspection 933183 - Catalent Belgium SA - 2015-05-28](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/ac4c5044-1790-4041-aba7-adab7c993bd2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 28, 2015 - [FDA Inspection 915621 - Catalent Belgium SA - 2015-02-13](https://www.globalkeysolutions.net/records/fda_inspections/catalent-belgium-sa/f4f28eeb-6ce0-48a4-8af1-4f384953e2d2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2015 ## Related Companies - [Glenmark Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d) - [MassBiologics](https://www.globalkeysolutions.net/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600) - [Gland Pharma Limited, Units I+II Pashamylaram Site](https://www.globalkeysolutions.net/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca) - [Dendreon Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/dendreon-pharmaceuticals-llc/3de4a8e5-8e34-4212-8862-ecd5256c6ffe) - [Ipca Laboratories Limited](https://www.globalkeysolutions.net/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a) - [Novartis Pharmaceuticals Corporation](https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47) - [Ipca Laboratories Limited](https://www.globalkeysolutions.net/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b) - [Kite Pharma, Inc.](https://www.globalkeysolutions.net/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f) - [Recipharm Monts](https://www.globalkeysolutions.net/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6) - [Steril-Gene Life Sciences Private Ltd](https://www.globalkeysolutions.net/companies/steril-gene-life-sciences-private-ltd/0885ef5e-2fd7-42c0-927d-7cf3c2410eec) ## Related Officers - [CSO](https://www.globalkeysolutions.net/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001) - [Gena Arcy, CSO](https://www.globalkeysolutions.net/people/gena-arcy-cso/5e73742f-22df-4750-82a8-430f86192916) - [recipient](https://www.globalkeysolutions.net/people/eric-kummer/4edd74cd-5152-4318-a7a3-3999746fcf4e) - [Compliance Officer at FDA](https://www.globalkeysolutions.net/people/christopher-d-leach/2a3c4b73-f082-4f33-aa2d-52d1abbb6d55) - [Compliance Officer](https://www.globalkeysolutions.net/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)